Most investors like the idea of getting in early on an up-and-coming stock. But doing so isn't always easy. Sometimes what seems to be a rising star can crash and burn.

We asked three Motley Fool contributors to pick monster stocks in the making to buy right now. Here's why they chose CRISPR Therapeutics (NASDAQ: CRSP), Ginkgo Bioworks (NYSE: DNA), and Novocure (NASDAQ: NVCR).

Prosper Junior Bakiny (CRISPR Therapeutics): Despite tremendous medical progress in the past few decades, there is still plenty of work to do. Drugmakers are in a race to discover breakthrough treatments for difficult-to-treat illnesses. Gene-editing leader CRISPR Therapeutics is one of them. This mid-cap biotech appears to be really close to earning its first major regulatory win.

Continue reading

Source Fool.com